logo
producten
DETAILS VAN DE PRODUCTEN
Huis > Producten >
HPV E7 Oncoprotein Test Kit for Cervical Cancer Screening with 15 min Results, Self-Sampling, and Direct Cancer Cell Protein Detection

HPV E7 Oncoprotein Test Kit for Cervical Cancer Screening with 15 min Results, Self-Sampling, and Direct Cancer Cell Protein Detection

MOQ: 1000 stuks
Prijs: USD
Standard Packaging: 1 stks/doos, 50 stks/doos, 100 stks/doos
Delivery Period: afhankelijk van bestelhoeveelheid
Betalingswijze: L/C, T/T
Supply Capacity: 50,000pcs per maand
Detailinformatie
Plaats van herkomst
China
Merknaam
FAMID
Certificering
NMPA,CE
Modelnummer
001
Testmethode:
Colloïdaal goud
Tijd voor het resultaat:
binnen 15 minuten
Monsterneming:
zelf verzamelen
Marketing:
Zoek naar de distributeurs/agenten wereldwijd
Productomschrijving
HPV E7 Oncoprotein Cervical Cancer Rapid Test Kit
Product Overview

Breakthrough new generation technology for cervical cancer screening that directly detects cancer cells and cervical cancer lesions.

Unlike traditional cervical cancer screening methods (TCT and HPV) that detect abnormal cells or HPV virus, our test assay directly identifies cancerous cells and cervical cancer lesions through E7 oncoprotein detection.

Key Features
  • 15-minute rapid test - no need to wait for lab results
  • Higher accuracy for cervical cancer screening
  • Self-sampling cervical brush technology
  • First rapid test kit worldwide to directly detect E7 oncoprotein
  • Identifies high-grade precancerous lesions before progression to cancer
E7 Oncoprotein and Cervical Cancer Progression

When E7 oncoprotein is expressed in large quantities, it causes cells to develop high-grade precancerous lesions until cancerous. Detection of E7 helps evaluate cervical precancerous lesions.

HPV E7 Oncoprotein Test Kit for Cervical Cancer Screening with 15 min Results, Self-Sampling, and Direct Cancer Cell Protein Detection 0
Comparison with Current Detection Methods
HPV E7 Oncoprotein Test Kit for Cervical Cancer Screening with 15 min Results, Self-Sampling, and Direct Cancer Cell Protein Detection 1
Clinical Advantages
  • Pap/TCT tests result in ASC-US population with abnormal cells but cannot detect cervical cancer cells and lesions
  • DNA tests provide HPV virus infection and types but cannot detect cervical cancer cells and lesions
  • E7 oncoprotein tests detect HPV-infected cells that become cancerous and directly identify oncoprotein expression
  • Chinese FDA registered, EU registered, and CE marked
  • Patented technology in China, USA, and other countries
Clinical Applications

Direct Detection: Use E7 oncoprotein rapid kit at hospitals, clinics, or for home testing to detect cervical cancer.

Combined with TCT/Pap Smear: Use E7 to further evaluate precancerous progression when only TCT testing is available.

Combined with HPV DNA Test: Improves diagnosis specificity of cervical lesions and provides referral basis for colposcopy.

For Positive TCT/HPV DNA Patients: Identify transient infections and assess disease progression risk.

Post-Surgery Patients: Assess recurrence risk and prognosis.

For Negative TCT/HPV DNA Patients: Detect lesions to avoid missed diagnosis when DNA tests show weak or false negatives.

Sample Collection Procedure

Cervical Exfoliated Cell Sample Extraction:

  • Use sampling cervical brush placed on transformation zone of cervix
  • Turn clockwise six times
  • Insert brush into test tube containing sample release agent
Pre-Sampling Requirements
  • Avoid intravaginal medicines, douching
  • Avoid menstrual periods - no sampling three days before/after menstruation
  • Do not sample during pregnancy
Postpone sampling if experiencing abnormal vaginal bleeding, heavy bleeding, excessive secretion, or thick secretion.
Instructions for Use
HPV E7 Oncoprotein Test Kit for Cervical Cancer Screening with 15 min Results, Self-Sampling, and Direct Cancer Cell Protein Detection 2
producten
DETAILS VAN DE PRODUCTEN
HPV E7 Oncoprotein Test Kit for Cervical Cancer Screening with 15 min Results, Self-Sampling, and Direct Cancer Cell Protein Detection
MOQ: 1000 stuks
Prijs: USD
Standard Packaging: 1 stks/doos, 50 stks/doos, 100 stks/doos
Delivery Period: afhankelijk van bestelhoeveelheid
Betalingswijze: L/C, T/T
Supply Capacity: 50,000pcs per maand
Detailinformatie
Plaats van herkomst
China
Merknaam
FAMID
Certificering
NMPA,CE
Modelnummer
001
Testmethode:
Colloïdaal goud
Tijd voor het resultaat:
binnen 15 minuten
Monsterneming:
zelf verzamelen
Marketing:
Zoek naar de distributeurs/agenten wereldwijd
Min. bestelaantal:
1000 stuks
Prijs:
USD
Verpakking Details:
1 stks/doos, 50 stks/doos, 100 stks/doos
Levertijd:
afhankelijk van bestelhoeveelheid
Betalingscondities:
L/C, T/T
Levering vermogen:
50,000pcs per maand
Productomschrijving
HPV E7 Oncoprotein Cervical Cancer Rapid Test Kit
Product Overview

Breakthrough new generation technology for cervical cancer screening that directly detects cancer cells and cervical cancer lesions.

Unlike traditional cervical cancer screening methods (TCT and HPV) that detect abnormal cells or HPV virus, our test assay directly identifies cancerous cells and cervical cancer lesions through E7 oncoprotein detection.

Key Features
  • 15-minute rapid test - no need to wait for lab results
  • Higher accuracy for cervical cancer screening
  • Self-sampling cervical brush technology
  • First rapid test kit worldwide to directly detect E7 oncoprotein
  • Identifies high-grade precancerous lesions before progression to cancer
E7 Oncoprotein and Cervical Cancer Progression

When E7 oncoprotein is expressed in large quantities, it causes cells to develop high-grade precancerous lesions until cancerous. Detection of E7 helps evaluate cervical precancerous lesions.

HPV E7 Oncoprotein Test Kit for Cervical Cancer Screening with 15 min Results, Self-Sampling, and Direct Cancer Cell Protein Detection 0
Comparison with Current Detection Methods
HPV E7 Oncoprotein Test Kit for Cervical Cancer Screening with 15 min Results, Self-Sampling, and Direct Cancer Cell Protein Detection 1
Clinical Advantages
  • Pap/TCT tests result in ASC-US population with abnormal cells but cannot detect cervical cancer cells and lesions
  • DNA tests provide HPV virus infection and types but cannot detect cervical cancer cells and lesions
  • E7 oncoprotein tests detect HPV-infected cells that become cancerous and directly identify oncoprotein expression
  • Chinese FDA registered, EU registered, and CE marked
  • Patented technology in China, USA, and other countries
Clinical Applications

Direct Detection: Use E7 oncoprotein rapid kit at hospitals, clinics, or for home testing to detect cervical cancer.

Combined with TCT/Pap Smear: Use E7 to further evaluate precancerous progression when only TCT testing is available.

Combined with HPV DNA Test: Improves diagnosis specificity of cervical lesions and provides referral basis for colposcopy.

For Positive TCT/HPV DNA Patients: Identify transient infections and assess disease progression risk.

Post-Surgery Patients: Assess recurrence risk and prognosis.

For Negative TCT/HPV DNA Patients: Detect lesions to avoid missed diagnosis when DNA tests show weak or false negatives.

Sample Collection Procedure

Cervical Exfoliated Cell Sample Extraction:

  • Use sampling cervical brush placed on transformation zone of cervix
  • Turn clockwise six times
  • Insert brush into test tube containing sample release agent
Pre-Sampling Requirements
  • Avoid intravaginal medicines, douching
  • Avoid menstrual periods - no sampling three days before/after menstruation
  • Do not sample during pregnancy
Postpone sampling if experiencing abnormal vaginal bleeding, heavy bleeding, excessive secretion, or thick secretion.
Instructions for Use
HPV E7 Oncoprotein Test Kit for Cervical Cancer Screening with 15 min Results, Self-Sampling, and Direct Cancer Cell Protein Detection 2
Sitemap |  Privacybeleid | De Goede Kwaliteit van China De Machine van rechts qPCR Leverancier. Copyright © 2022-2026 Guangzhou BioKey Healthy Technology Co.Ltd . Alle rechten voorbehoudena.